Bone marrow aspiration (BMA) and biopsy (BMTB) 
Introduction:
Obtaining bone marrow, by aspiration and biopsy is critical for diagnosis, prognostic evaluation and response monitoring in Haematological malignancies 1,2 . BMTB is superior to assess cellularity, degree of fibrosis, marrow architecture and focal marrow infiltration in lmphoma. It can also provide sample for immunohistochemistry although not for cytogenetic study. Biopsy is also required when a 'dry tap ' or 'blood tap' commonly associated with acute megakaryoblastic leukemia (AML-FAB-M7), acute panmyelosis with myelofibrosis and primary myelofibrosis (PMF) 3, 4 . Abnormal localization of immature precursors (ALIP) in MDS and nodular partial remission (nPR) in chronic lymphocytic leukaemia (CLL) can be assessed only by BMTB 5 . BM aspirate along with trephine biopsy is required for diagnosis and staging of nonHodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL) 6, 7 .
Methods:
This study was done at the Department of Haematology, Dhaka Medical College Hospital, Dhaka from January to June 2013. The diagnosis of lymphoma was confirmed by lymph node biopsy and histopathology prior to staging bone marrow biopsy. Under informed consent, BMTB was done in posterior superior iliac spine under strict aseptic condition and local anaesthesia using Islam needle. Obtained core was preserved in formalin and touch imprints were prepared. Imprints were stained with Leishman stain and core was sent to a collaborating laboratory for histopathology.
.
Results:
In a period of 6 month, BMTB was performed in 53 cases. Out of theses 18 cases (34.61%) was AA. 4 cases each of ALL, lymphoma and PMF followed by acute myeloid leukaemia (AML) (n=3, 5.76%), chronic myeloid leukaemia (CML) and secondaries (n=2, 3.84%) [ fig. 1 ]. 1 case each of multiple myeloma (MM) and polycythaemia rubra vera (PRV). 5 cases showed reactive changes and 6 cases showed normal active marrow. 2 cases showed erythroid hyperplasia (both done to stage lymphoma) and elements were very scanty and megakaryocytes were virtually absent [ fig. 3 ]. The second commonest indication was failure of bone 1 case showed megakaryocytic hyperplasia (done to investigate thrombocytopenia). BMTB was done to assess the marrow cellularity in AA (n=18, 33.96%) which constitute an essential diagnostic criteria. In AA bone marrow was grossly hypocellular with increased fat spaces. Erythropoietic and granulopoietic marrow aspiration (n=17. 32.08%) followed by staging of lymphoma (n=12, 22.64%). Out of 17 cases of failed aspiration, 65% was blood tap (yielding only blood in aspiration; n=11) and 35% was dry tap (yielding no blood or marrow particles in aspiration; n=6). Out of the 17 failed aspiration cases, 41% (n=7) was due to MPN namely PMF (23%), PRV (6%) and CML (12%). Other causes of failed aspirations were Multiple myeloma (6%), ALL (17%), AML (18%) and secondary deposits in the bone marrow (6%) [ fig. 2 ]. Marrow in PMF was grossly hypocellular with widening of bony trabeculae, marked depression of cellular elements, gross fibrosis and increase in reticulin fibres [ fig. 4 ]. In the early phase of PMF bony tissue showed mild degree of proliferation of reticulin fibres. Cellular elements were relatively reduced and few megakaryocytes were seen [ fig. 5 ]. Imprint in both cases were acellular. The commonest complication of BMTB was mild haemorrhage. Increased bleeding was observed in a case of polycythaemia vera.
Fig.-4: Fibrotic phase PMF: (A) Massive widening of bony trabeculae and hypocellularity, (B) Streamlining of megakaryocytes. Abnormal megakaryocyte with cloud like nuclei (×10 objective) [H & E stain].

Fig.-5: PMF features in blood and marrow: (A) peripheral blood shows dacryocytes (arrow head marked) and myeloblast (oil immersion objecive); (B) trephine biopsy shows large megakaryocytes with bulbous deeply lobated nuclei. (×40 objective); (C & D) marked reticulin fibrosis in marrow (× 40 and ×10 objective respectively) [A -Leishman stain; B -H & E stain; C and D -Silver impregnation stain].
Discussion:
BMTB is a relatively safe procedure with adverse event reported in only .12 to .34% of procedures. Major risk factor for haemorrhgae was MPD and we found increased bleeding in a case of polycythaemia vera 8 . Aspiration failure was found attributable to fibrosis in 58.8 % cases (n=10). Cases included ALL, AML and PMF [8] [9] [10] . PMF comprised 23.5% of the cases which is similar to another study by Barua et al. 10 This was higher than found by Humphries 9 (13.8%). This is likely due to the small number of patients included in the study. In 35.3% cases of aspiration failure may be due to acute leukaemia similar to 41.3% demonstrated by Barua et al 10 . BMTB is recommended in the diagnostic work up for AA to establish the degree of cellularity and exclude differential diagnoses like hypocellular ALL and hypocellular MDS 11 . 1 patient labeled as severe aplastic anaemia (SAA) out of 18 cases of AA, evolved into ALL 2 months later while she was still on CSA. Biopsy finding in this case showed focal lymphoid aggregate. Islam et al. 12 found that 10% of the AA cases evolving to acute leukaemia. The rest of the cases of AA (n=17) biopsy findings were typical of AA [ figure 3 ]. In one case of AA, aspirate showed only mildly depressed megakaryopoiesis but biopsy showed no megakaryocytes underscoring the importance of obtaining a core of bone marrow to avoid false impression of patchy haemopoiesis in AA. Staging of lymphoma specially NHL requires a bone marrow biopsy rather than aspiration as focal infiltrates may be missed by aspiration as such cases can be upstaged after bone marrow biopsy. BMTB was done in 12 cases of lymphoma (3 HL and 9 NHL). In contrast to Subramanium et al. 7 and Hamid & Naeem 13 BMTB failed to upstage HL in our study. 1 case of HL stage IIB BMA showed features of lymphoid infiltration, however, in biopsy no infiltration was found. This was probably aspiration from a normal lymphoid nodule in the bone marrow. 22.22 % of NHL cases (n=2) BM biopsy showed lymphomatous infiltration which is higher than the study by Brunning & McKenna 14 probably due to larger sample size. Both the cases in current study were at clinical stage IIIB upstaged to IVB after biopsy.
Conclusion:
This was a small study of 53 cases. We strongly believe that extending this study can produce valuable results. The necessity of BMTB in NHL particularly merits further evaluation with higher number of patients. However, in resource-poor setting as ours, performing BMTB in strict indications can limit diagnostic failure in patients.
